Insider trading · Q3 2026 · CIK 1583107

Theravance Biopharma, Inc. (TBPH) insider trading.

In Q3 2026, insiders at Theravance Biopharma, Inc. reported 39 non-derivative transactions on 19 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $6.1M.

Transactions
39
Purchases (P)
0
Sales (S)
8
Net shares, P minus S
-356,975
Insiders
12
Last filed
2026-09-28

Insiders

InsiderRelationshipTransactionsBuysSales
Winningham Rick EDirector, Officer · CHIEF EXECUTIVE OFFICER600
Farnum RhondaOfficer · SVP, COMM & MEDICAL AFFAIRS603
Samaha EliTenPercentOwner505
Sawaf AzizOfficer · SVP & CHIEF FINANCIAL OFFICER400
Grimaud Brett A.Officer · SVP, GEN COUNSEL AND SECRETARY400
Miller AineOfficer · SVP, DEV & HEAD OF IRE OFFICE300
Mitchell Dean JDirector200
Pakianathan DeepikaDirector200
Smaldone Alsup LaurieDirector200
O'Connor DonalDirector200
Gray SusannahDirector200
Weiss Asset Management LP / WEISS ANDREW M / WAM GP LLCOther100

Transactions

39 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-23Weiss Asset Management LP / WEISS ANDREW M / WAM GP LLCJ (D)7,457,060$170Form 4
2026-09-23Mitchell Dean JD (D)91,204—6,009Form 4
2026-09-23Mitchell Dean JD (D)6,009—0Form 4
2026-09-23Pakianathan DeepikaD (D)6,009—0Form 4
2026-09-23Pakianathan DeepikaD (D)58,065—6,009Form 4
2026-09-23Winningham Rick ED (D)1,382,272—228,750Form 4
2026-09-23Winningham Rick ED (D)92,567—0Form 4
2026-09-23Winningham Rick ED (D)23,400—0Form 4
2026-09-23Winningham Rick ED (D)151,875—76,875Form 4
2026-09-23Winningham Rick ED (D)76,875—0Form 4
2026-09-23Smaldone Alsup LaurieD (D)74,980—6,009Form 4
2026-09-23Smaldone Alsup LaurieD (D)6,009—0Form 4
2026-09-23O'Connor DonalD (D)74,204—6,009Form 4
2026-09-23O'Connor DonalD (D)6,009—0Form 4
2026-09-23Gray SusannahD (D)42,137—6,009Form 4
2026-09-23Gray SusannahD (D)6,009—0Form 4
2026-09-23Farnum RhondaD (D)89,062—0Form 4
2026-09-23Farnum RhondaD (D)124,414—89,062Form 4
2026-09-23Sawaf AzizD (D)108,436—23,439Form 4
2026-09-23Sawaf AzizD (D)204,966—131,875Form 4
2026-09-23Sawaf AzizD (D)23,439—0Form 4
2026-09-23Grimaud Brett A.D (D)107,812—23,439Form 4
2026-09-23Grimaud Brett A.D (D)23,439—0Form 4
2026-09-23Grimaud Brett A.D (D)223,917—131,251Form 4
2026-09-23Miller AineD (D)96,718—0Form 4
2026-09-23Miller AineD (D)93,108—96,718Form 4
2026-09-15Farnum RhondaS (D)3,328$17.03220,133Form 4
2026-09-15Farnum RhondaS (D)6,657$17.03213,476Form 4
2026-09-15Farnum RhondaS (D)3,329$17.03223,461Form 4
2026-08-20Winningham Rick EF (D)20,034$16.951,611,022Form 4
2026-08-20Farnum RhondaF (D)5,667$16.95226,790Form 4
2026-08-20Sawaf AzizF (D)8,112$16.95336,841Form 4
2026-08-20Grimaud Brett A.F (D)7,952$16.95355,168Form 4
2026-08-20Miller AineF (D)6,258$16.95189,826Form 4
2026-07-07Samaha EliS (D)5,564$17.179,167,489Form 4
2026-07-06Samaha EliS (D)1,400$17.049,173,053Form 4
2026-07-01Samaha EliS (D)37,799$179,174,453Form 4
2026-06-30Samaha EliS (D)25,027$17.139,212,252Form 4
2026-06-29Samaha EliS (D)273,871$17.239,237,279Form 4

Transaction codes in this quarter

Get TBPH insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1583107&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · Theravance Biopharma, Inc. on SEC.gov

Questions

Are insiders buying or selling Theravance Biopharma, Inc. (TBPH)?

In Q3 2026, insiders at Theravance Biopharma, Inc. reported 39 non-derivative transactions on 19 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $6.1M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Theravance Biopharma, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/tbph.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.